NCT03754595|Unknown
Loading search results
Sponsor study identifier
interventional
60
0 countries
N/A
Study Start
December 1, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Pancreatic cancer is extremely malignant, with a low sensibility to chemotherapy and radiotherapy, and a poor prognosis. Surgical treatment is very important for pancreatic cancer. Laparoscopic pancreatoduodenectomy is a standard radical procedure we are going to compare and discuss the advantages of 2D and 3D Laparoscopic pancreatoduodenectomy in our RCT study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 25, 2018
Actual (reported)November 27, 2018
Actual (reported)December 1, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Overall survival
overall survival duration after surgical treatment
60 month
Overall complications
Up to postoperative 30 days
Operative time
12 hours
Pancreatic fistula
Up to postoperative 30 days
Patients with pancreatic cancer treated by 2D Laparoscopic pancreatoduodenectomy
Patients with pancreatic cancer treated by 3D Laparoscopic pancreatoduodenectomy
Patients with pancreatic cancer treated by 3D Laparoscopic pancreatoduodenectomy
2D Laparoscopic pancreatoduodenectomy
Menghua Dai, MD
Peking Union Medical Coll3ge hospital
First Submitted
November 25, 2018
First Posted
November 27, 2018
Study Start
December 1, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 27, 2018
Record last verified: 2018-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: